Stay updated on GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial page.

Latest updates to the GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange Detected- Minor user interface and formatting updates with no changes to study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedIntroducing a major status notice about funding-related operation limitations and updating the version to v3.2.0. The page now communicates potential processing delays and directs users to official sources, marking a shift in reliability and availability information.SummaryDifference2%

- Check49 days agoChange DetectedAdded a new version tag (v3.1.0) and removed several drug-safety related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating a content restructuring.SummaryDifference0.2%

- Check63 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed; no changes to core content or pricing are detected.SummaryDifference0.1%

- Check70 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%

- Check77 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as the introduction of topics related to drug safety and pathological conditions. Notably, previous topics on hypertension and related conditions have been removed.SummaryDifference2%

Stay in the know with updates to GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial page.